UNIDRIVE Select System
Karl Storz SE & CO. KG · Decision date Sep 18, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision for the UNIDRIVE Select System, a hysteroscope and accessories, on September 18, 2026, under 510(k) number K261102. Karl Storz SE & CO. KG of Tuttlingen, Germany, is the applicant; the submission was received April 3, 2026, and reviewed in the Obstetrics/Gynecology panel under regulation 884.1690 with product code HIH. The record lists a traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan.
SESE means the device was cleared to market as substantially equivalent to a predicate; it is not a PMA approval. The available record does not identify the predicate device, the specific components or changes submitted, or any performance data, so the technical basis for the equivalence finding remains unknown. The decision letter excerpt also names KARL STORZ Endoscopy-America, Inc. as submitter, a U.S. affiliate of the applicant.
No summary statement is present in the source data, and no clinical, efficacy or labeling conclusions are drawn here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Obstetrics/Gynecology
- Decision date
- Sep 18, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261102
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Karl Storz SE & CO. KG
- Product code
- HIH
- Decision code
- SESE
- Decision date
- Sep 18, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Hysteroscope (And Accessories).
- Applicant
- Karl Storz SE & CO. KG
- Product code
- HIH
- FDA device class
- 2
FDA decision timeline
K261102 received
Application receipt date recorded by FDA.
K261102 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code HIH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Karl Storz SE & CO. KG | 510(k) clearance | Sep 25, 2026 | FDA | |
| Zhejiang Geyi Medical Instrument Co., Ltd. | 510(k) clearance | Sep 8, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Karl Storz SE & CO. KG
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Tuttlingen
Sources and methodology
- Original FDA record: K261102
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
